Contemporary update on neoadjuvant therapy for bladder cancer.
about
YBX1 promotes tumor growth by elevating glycolysis in human bladder cancerPD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells.
P2860
Contemporary update on neoadjuvant therapy for bladder cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Contemporary update on neoadjuvant therapy for bladder cancer.
@en
Contemporary update on neoadjuvant therapy for bladder cancer.
@nl
type
label
Contemporary update on neoadjuvant therapy for bladder cancer.
@en
Contemporary update on neoadjuvant therapy for bladder cancer.
@nl
prefLabel
Contemporary update on neoadjuvant therapy for bladder cancer.
@en
Contemporary update on neoadjuvant therapy for bladder cancer.
@nl
P2860
P356
P1476
Contemporary update on neoadjuvant therapy for bladder cancer.
@en
P2093
Daniel P Nguyen
George N Thalmann
P2860
P2888
P304
P356
10.1038/NRUROL.2017.30
P407
P577
2017-03-14T00:00:00Z